MedPath
NMPA Approval

Atomoxetine Hydrochloride Oral Solution

国药准字H20244163

June 28, 2024

Drug Information

盐酸托莫西汀口服溶液

口服溶液剂

0.4%(100ml∶0.4g)(按C₁₇H₂₁NO计)

化学药品

June 28, 2024

Company Information

Applicant Company

浙江省兰溪市康恩贝大道1号

Manufacturing Company

浙江省兰溪市康恩贝大道1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸托莫西汀口服溶液 - NMPA 批准文号 | MedPath